Addressing dependent amphetamine use: A place for prescription

Drug and Alcohol Review

Volumn 15, Issue 2, 1996, Pages 189-195

  Lintzeris, Nick ^a   Holgate, Fran ^a   Dunlop, Adrian ^a  

^a TURNING POINT ALCOHOL AND DRUG CENTRE   (Australia)

Author keywords

Amphetamine related harm; Amphetamines; Substitution therapy

Indexed keywords

EID: 0030534189     PISSN: 09595236     EISSN: None     Source Type: Journal    
DOI: 10.1080/09595239600185841     Document Type: Review

References (29)

1. National Drug Strategy. Drug use and exposure in the Australian community. Canberra: Commonwealth of Australia, 1993.
2. Victorian Drug Strategy Statistics Handbook Health and Community Services Promotions and Media Unit, 1993.
3. Hall W, Hando J. Route of administration and adverse effects of amphetamine use among young adults in Sydney, Australia. Addiction 1994;13: 277-284.
4. Hando J, Hall W. Amphetamine use and HIV risk-taking among young Sydney adults. Addiction 1994;89:79-85.
5. American Psychiatric Association. DSM-IV (Diagnostic and statistical manual of mental disorders, 4th edn. Washington DC: American Psychiatric Association Press, 1994.
6. Lago JA, Kosten TR. Stimulant withdrawal. Addiction 1994;89:1477-1481.
7. Davies JB, Coggans N. Media- and school-based approaches to drug education. In: Strang J, Gossop M, eds. Heroin addiction and drug policy: the British system. Oxford: Oxford University Press 1994;311-321.
8. Chen R, Mattick, RP, Baillie A. Clients of treatment service agencies. Canberra: Commonwealth Government Printer, 1992.
9. Kranzler HR, Bauer LO. Bromocriptine and cocaine cue reactivity in cocaine-dependent patients. Br J Addict 1992;87:1537-1548.
10. Meyer RE. New pharmacotherapies for cocaine dependence ... revisited. Arch Gen Psych, 1992;49: 900-904.
11. Kokkinidis L, Zacharko RM. Response sensitisation and depression following long-term amphetamine treatment in a self-stimulation program. J Clin Psychol 1981;48:442-444.
12. Tennant FS, Sagherian AA. Double-blind comparison of amantadine and bromocriptine for ambulatory withdrawal from cocaine dependence. Arch Int Med, 1987;147:109-112.
13. Berger P, Gerwin FH, Kosten TR. Treatment of cocaine abuse with mazindol. Lancet, 1989;1:283.
14. Kosten TR, Morgan CM, Falcione J, Schottenfeld RS. Pharmacotherapy for cocaine-abusing methadone-maintained patients using amantadine or desipramine. Arch Gen Psychol, 1992;49:894-898.
15. Arndt IO, Dorozynsky L, Woody GE, McLellan AT, O'Brien CP. Desipramine treatment of cocaine dependence in methadone maintenance patients. Arch Gen Psychol, 1992;49:904-908.
16. Pollack MH, Rosenbaum JF. Fluoxetine treatment of cocaine abuse in heroin addicts. J Clin Psychol, 1991;52:31-32.
17. O'Brien CP. Overview. The treatment of drug dependence. Addiction 1994;89:1565-1569.
18. Mattick RP. A Treatment outline for approaches to opiod dependence: quality assurance project. Canberra: Australian Government Printer, 1994.
19. Mattick RP, Darke S. Drug replacement treatments: is amphetamine substitution a horse of a different colour? Drug Alcohol Rev 1995;14:389-394.
20. Power R. Drug trends since 1968. In: Strang J, Gossop M, eds. Heroin addiction and drug policy: the British system. Oxford: Oxford University Press, 1994;29-41.
21. Hawks D, Mitcheson M, Ogborne A, Edwards G. Abuse of methylamphetamine. Br Med J 1969;85: 715-721.
22. Fleming P, Roberts D. Is the prescription of amphetamine justified as a harm reduction measure? J Roy Soc Hlth 1994;June:127-131.
23. Pates R. Speed on prescription. Druglink;9:16-17.
24. Merrill J, Tetlow T. Compliance with dexamphetamine detoxification or maintenance determined by urine testing. In: VI International Conference on the Reduction of Drug Related Harm, Florence, Italy 1995.
25. Sherman JP. Dexamphetamine for 'speed' addiction, Med J Aust 1990;153:306.
26. Ford P. Amphetamine prescribing intervention. SCODA Newsletter, December-January: 1992-93.
27. Sato M, Chen C, Akiyama K, Otsuki S. Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis. Biol Psychol 1983;18:429-440.
28. Chesher GB. Pharmacology of the sympathomimetic psychostimulants. In: Burrows D, Flaherty B, MacAvoy M, eds. Psychostimulant use in Australia. Canberra: Australian Government Publishing Service, 1993:9-30.
29. Fromberg E. Cocaine and pregnancy, hype or science: a review. In: Burrows D, Flaherty B, MacAvoy M, eds. Psychostimulant use in Australia. Canberra: Australian Government Publishing Service, 1993:38.